Raab & Moskowitz Asset Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-200	Closed	-$12K	–	413
2019 Q4	$12K	Buy	+200	New	+$12.2K	﹤0.01%	383
2015 Q1	–	Sell	-750	Closed	-$50K	–	308
2014 Q4	$50K	Buy	+750	New	+$49.9K	0.03%	193

Other funds holding PJP

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Raab & Moskowitz Asset Management's PJP Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2020, closing a stake of 200 shares — an estimated $12K sold.

Raab & Moskowitz Asset Management first reported a position in PJP in Q4 2014 and held it in 2 quarters. The position peaked at $50K in Q4 2014. 86 funds tracked by Wall St. Rank hold PJP as of Q1 2020.

Raab & Moskowitz Asset Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 200 Invesco Pharmaceuticals ETF shares in Q1 2020, an estimated $12K.
Raab & Moskowitz Asset Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and held it in 2 quarters.
Raab & Moskowitz Asset Management's Invesco Pharmaceuticals ETF position peaked at $50K in Q4 2014.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.